简介内容:BTK-IN-17 is a selective, orally active inhibitor of Bruton´s Tyrosine Kinase (BTK) with an inhibition concentration (IC50) value of nM. It effectively reduces the expression of phosphorylated BTK at Tyrosine 223 (p-BTK Y223) and phosphorylated Phospholipase C Gamma 2 at Tyrosine 1217 (p-PLCγ2 Y1217), demonstrating anti-inflammatory properties.